by Larry Yost | Dec 16, 2025 | Press Release
American Medical Association Establishes Category III CPT Code for Procedure Associated with the Use of MuReva Phototherapy’s LED-based Photobiomodulation Therapy Device Obtaining this CPT code is an initial step to achieving reimbursement for the use of MuReva...
by Larry Yost | Oct 28, 2025 | Press Release
MuReva Phototherapy Presents Data during 2025 ASTRO Meeting Confirming Safety and Efficacy of the Company’s LED-based Photobiomodulation Therapy Device Study confirmed the safety and the ability of the company’s LED-based photobiomodulation therapy breakthrough device...
